Evofem Biosciences Inc. (EVFM) Fundamentals

Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.
SHARE INFORMATION
Market Cap$ 14,365,977
Shares Outstanding12,713,254
Float12,526,525
Percent Float98.53%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 8,244,000
Latest Fiscal EPS$ -24.30
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions160
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months3,016,945
Institutional Holdings Percent23.4%
Institutional Sold Previous 3 Months11,279,332
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months3,900,000
Insider Holdings Percent2.2
Insider Sold Previous 3 Months660,000
Insider Shares Owned4,038,003
TRADING INFO
52 Week High$ 21.30
52 Week Low$ 1.01
52 Week High Change$ -94.11
21 Day Moving Average$ 2.1284
21 Day Extended Moving Average$ 2.0174
50 Day Moving Average$ 3.8201
50 Day Extended Moving Average$ 3.3614
200 Day Moving Average$ 7.5878
200 Day Extended Moving Average$ 9.1147
10 Day Average Volume697,766
20 Day Average Volume482,087
30 Day Average Volume406,423
50 Day Average Volume309,040
Alpha-0.004596
Beta0.0109
Standard Deviation0.378134
R20.000002
7 Day Price Change$ 0.01
7 Day Percent Change0.89%
21 Day Price Change$ -1.58
21 Day Percent Change-58.36%
30 Day Price Change$ -2.26
30 Day Percent Change-66.67%
Month to Date Price Change$ -1.51
Month to Date Percent Change-57.2%
Quarter to Date Price Change$ -3.97
Quarter to Date Percent Change-77.84%
180 Day Price Change$ -6.95
180 Day Percent Change-86.02%
200 Day Price Change$ -9.18
200 Day Percent Change-89.04%
Year to Date Price Change$ -4.50
Year to Date Percent Change-79.94%

Evofem Biosciences Inc. (EVFM) Key Ratios

PROFITABILITY
EBIT Margin-3,412.5%
EBITDA Margin-3,394.8%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin50.8%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 7,139,000
Revenue Per Share$ 0.5615
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-0.10
Total Debt To Equity8.70
Int Coverage0.00
Current Ratio0.20
Leverage Ratio-1.50
Quick Ratio0.10
Long Term Debt To Capital0.78
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 130,697,651
Price to Sales2.0123
Price to Free Cash-0.10
PE High Last 5 Years-0.20
Price To Book8.40
Price To Cash Flow0.00
PE Low Last 5 Years-0.90
Price to Tangible Book-0.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.90
Invoice Turnover0.50
Assets Turnover0.10
Return Assets-284.70
Return on Equity400.23
Return on Capital-146.30

Evofem Biosciences Inc. (EVFM) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEOSaundra Pelletier
Emplyoees199
Last AuditUE
CIK0001618835
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address12400 High Bluff Drive
Suite 600
San Diego, CA 92130
Websitehttps://www.evofem.com
Facsimile+1 844 828-2010
Telephone+1 858 550-1900
Emailaraskopf@evofem.com


Your Recent History
NASDAQ
EVFM
Evofem Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.